Physician profile
Rose M Mathew
NPI 1679638886
$1,039.49
in general payments reported to CMS, 2019-2025
19 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.71 · 2021: $117 · 2022: $516 · 2023: $32.52 · 2024: $92.60 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $346.35 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $192.94 | 2022 | |
| Eisai INC. | $72.85 | 2024 | |
| Genzyme Corporation | $68.16 | 2019-2025 | |
| Lundbeck LLC | $47.16 | 2025 | Vyepti |
| Biogen, INC. | $37.36 | 2019-2025 | Skyclarys |
| Novartis Pharmaceuticals Corporation | $35.88 | 2021-2022 | |
| Celgene Corporation | $30.14 | 2022 | |
| Emd Serono, INC. | $29.31 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $25.21 | 2022 | |
| Springworks Therapeutics, INC. | $20.70 | 2025 | Gomekli |
| Pfizer INC. | $19.75 | 2024 | |
| Grifols USA, LLC | $19.71 | 2021 | |
| Ge Healthcare | $17.88 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.15 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.67 | 2019 | |
| Medtronic USA, INC. | $14.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.30 | 2021 | |
| Sunovion Pharmaceuticals INC. | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.